What is the role of steroids, such as methylprednisolone (corticosteroid) or prednisone (corticosteroid), in the treatment of anaphylaxis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Role of Steroids in Anaphylaxis Treatment

Steroids are not first-line treatment for anaphylaxis and should never delay or replace epinephrine administration, but may be used as adjunctive therapy to potentially prevent biphasic or protracted reactions.

First-Line Treatment Priority

Epinephrine is unequivocally the first-line treatment for anaphylaxis for several critical reasons:

  • It addresses multiple pathophysiologic mechanisms of anaphylaxis simultaneously
  • It has rapid onset of action within minutes
  • It provides vasoconstrictive, inotropic, chronotropic, and bronchodilatory effects
  • Failure to administer epinephrine early has been repeatedly implicated in anaphylaxis fatalities 1

Role of Corticosteroids

Mechanism and Timing

  • Corticosteroids have a slow onset of action (4-6 hours after administration) 2
  • They work by:
    • Binding to glucocorticoid receptors
    • Translocating to the nucleus
    • Inhibiting gene expression and production of inflammatory mediators 2

Evidence for Use

  • Limited scientific evidence supports their efficacy in acute anaphylaxis management
  • No randomized controlled trials demonstrate clear benefit 2
  • Systemic corticosteroids are often recommended to prevent biphasic or protracted food-induced allergic reactions, but little data support their use 2

Current Guideline Recommendations

  1. NIAID Guidelines (2010): Include corticosteroids as part of continuation of adjunctive treatment after patient discharge:

    • Prednisone daily for 2-3 days 2
  2. Joint Task Force Practice Parameters (2005): Consider systemic glucocorticosteroids for:

    • Patients with history of idiopathic anaphylaxis or asthma
    • Patients experiencing severe or prolonged anaphylaxis
    • Dosage: IV steroids every 6 hours (1.0-2.0 mg/kg/day) or oral prednisone (0.5 mg/kg) 2
  3. 2020 Practice Parameters Update: Emphasizes that glucocorticoids:

    • Have no proven role in treating acute reactions
    • Are ineffective in treating acute symptoms
    • May not result in clinical improvement for 4-6 hours after administration 2

Potential Benefits of Corticosteroids

  • May reduce length of hospital stay 2, 3
  • May help prevent biphasic or protracted reactions (though evidence is limited) 2
  • Should be continued for 2-3 days after the initial reaction 2

Important Cautions

  1. Never delay epinephrine: Corticosteroids should never be administered prior to, or in place of, epinephrine 2

  2. Potential for allergic reactions: Rarely, patients can develop anaphylaxis to corticosteroids themselves, particularly:

    • Succinate-containing preparations (hydrocortisone, methylprednisolone) 4, 5
    • More common in severe atopic asthmatics with previous exposure to parenteral corticosteroids 4
  3. Limited acute benefit: Given their slow onset of action, steroids have minimal impact on the acute phase of anaphylaxis 2

Practical Administration Guidelines

When used as adjunctive therapy:

  • Timing: After epinephrine administration and stabilization
  • Dosage options:
    • Methylprednisolone: 1.0-2.0 mg/kg IV every 6 hours 2
    • Prednisone: 0.5 mg/kg orally 2
    • Duration: Continue for 2-3 days 2

Summary of Treatment Algorithm

  1. First: Administer epinephrine IM (anterior-lateral thigh)
  2. Second: Provide supportive care (oxygen, IV fluids as needed)
  3. Third: Consider H1 antihistamines for cutaneous symptoms
  4. Fourth: Consider corticosteroids as adjunctive therapy, particularly for:
    • Patients with history of asthma
    • Severe or prolonged reactions
    • Prevention of potential biphasic reactions

Remember that the evidence supporting corticosteroid use in anaphylaxis is limited, and their primary value may be in preventing prolonged or biphasic reactions rather than treating the acute phase.

References

Research

Epinephrine and its use in anaphylaxis: current issues.

Current opinion in allergy and clinical immunology, 2010

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Corticosteroids in management of anaphylaxis; a systematic review of evidence.

European annals of allergy and clinical immunology, 2017

Research

Clinical evaluation of anaphylactic reactions to intravenous corticosteroids in adult asthmatics.

Respiration; international review of thoracic diseases, 2002

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.